Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2009-6-22
pubmed:abstractText
The rising incidence of autoimmune diseases such as multiple sclerosis (MS) in developed countries might be due to a more hygienic environment, particularly during early life. To investigate this concept, we developed a model of neonatal exposure to a common pathogen-associated molecular pattern, LPS, and determined its impact on experimental autoimmune encephalomyelitis (EAE). Mice exposed to LPS at 2 wk of age showed a delayed onset and diminished severity of myelin oligodendrocyte glycoprotein (MOG)-induced EAE, induced at 12 wk, compared with vehicle-exposed animals. Spinal cord transcript levels of CD3epsilon and F4/80 were lower in LPS- compared with PBS-exposed EAE animals with increased IL-10 levels in the LPS-exposed group. Splenic CD11c(+) cells from LPS-exposed animals exhibited reduced MHC class II and CD83 expression but increased levels of CD80 and CD86 both before and during EAE. MOG-treated APC from LPS-exposed animals stimulated less T lymphocyte proliferation but increased expansion of CD4(+)FoxP3(+) T cells compared with APC from PBS-exposed animals. Neuropathological studies disclosed reduced myelin and axonal loss in spinal cords from LPS-exposed compared with PBS-exposed animals with EAE, and this neuroprotective effect was associated with an increased number of CD3(+)FoxP3(+) immunoreactive cells. Analyses of human brain tissue revealed that FoxP3 expression was detected in lymphocytes, albeit reduced in MS compared with non-MS patients' brains. These findings support the concept of early-life microbial exposure influencing the generation of neuroprotective regulatory T cells and may provide insights into new immunotherapeutic strategies for MS.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1550-6606
pubmed:author
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
183
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
298-309
pubmed:meshHeading
pubmed-meshheading:19542441-Animals, pubmed-meshheading:19542441-Animals, Newborn, pubmed-meshheading:19542441-Brain, pubmed-meshheading:19542441-Cell Differentiation, pubmed-meshheading:19542441-Cell Movement, pubmed-meshheading:19542441-Cells, Cultured, pubmed-meshheading:19542441-Coculture Techniques, pubmed-meshheading:19542441-Dendritic Cells, pubmed-meshheading:19542441-Encephalomyelitis, Autoimmune, Experimental, pubmed-meshheading:19542441-Female, pubmed-meshheading:19542441-Forkhead Transcription Factors, pubmed-meshheading:19542441-Immune Tolerance, pubmed-meshheading:19542441-Interleukin-10, pubmed-meshheading:19542441-Lipopolysaccharides, pubmed-meshheading:19542441-Mice, pubmed-meshheading:19542441-Mice, Inbred C57BL, pubmed-meshheading:19542441-Multiple Sclerosis, pubmed-meshheading:19542441-Neuroprotective Agents, pubmed-meshheading:19542441-Severity of Illness Index, pubmed-meshheading:19542441-T-Lymphocytes, Regulatory
pubmed:year
2009
pubmed:articleTitle
Early life exposure to lipopolysaccharide suppresses experimental autoimmune encephalomyelitis by promoting tolerogenic dendritic cells and regulatory T cells.
pubmed:affiliation
Department of Medicine, University of Alberta, Edmonton, Canada.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, Non-U.S. Gov't